Spectral AI (MDAI) Company Overview

Profile

Full Name:

Spectral AI, Inc.

Sector:

Healthcare

Country:

United States

IPO:

April 6, 2021

Indexes:

Not included

Description:

MDAI, also known as Spectral AI, is a technology company that uses advanced artificial intelligence to analyze and interpret spectral data. Their solutions help industries like agriculture and healthcare improve decision-making and efficiency by providing insights from complex data patterns.

Key Details

Price

$2.09

Annual Revenue

$18.06 M(-28.82% YoY)

Annual EPS

-$1.48(-697.41% YoY)

Annual ROE

-405.44%

Beta

0.81

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 13, 24 HC Wainwright & Co.
Buy
Aug 12, 24 Northland Capital Markets
Outperform
Jul 18, 24 HC Wainwright & Co.
Buy
Jan 23, 24 BTIG
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
MDAI
globenewswire.comFebruary 7, 2025

DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the completion of its data analytics for its U.S. Burn Pivotal Study.   One of the largest domestic burn studies ever conducted, the U.S. Burn Pivotal Study is designed to validate the AI-driven algorithm used by the Company's DeepView® System for its burn indication. Spectral AI's DeepView® System is a predictive medical device and associated software that assesses the healing potential of burn wounds by combining multispectral imaging with an AI-driven algorithm trained and tested against a proprietary database of more than 340 billion clinically-validated data points. By distinguishing between healing and non-healing tissue, the DeepView® System provides an immediate and binary prediction of wound healing on the same day of injury, benefiting clinical decision-making regarding next step treatment.

Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
MDAI
globenewswire.comDecember 31, 2024

DALLAS, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, that uses multi-spectral imaging and algorithms to predict burn healing potential, today announced instructions for retail investors on how to exercise any publicly-traded warrants (NASDAQ: MDAIW). The warrant exercise process includes the following steps:

Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
MDAI
globenewswire.comDecember 2, 2024

DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced the successful completion of truthing for all images gathered from burn centers across the United States. This milestone represents a pivotal step in training the Company's proprietary DeepView® System to predict wound healing outcomes accurately. Having completed the process for burn centers, Spectral AI is now initiating truthing for images collected from emergency departments and emergency rooms nationwide, expanding the scope of the DeepView® System's capabilities.

Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
MDAI
globenewswire.comNovember 19, 2024

DALLAS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced the successful completion of an approximate $5.0 million equity financing in an at-the-market transaction. The closing is to be completed in two tranches. Part of the proceeds will be used for the retirement of its outstanding obligations with Yorkville Advisors. This transaction supports Spectral AI's growth trajectory and progress toward a submission to the U.S. Food and Drug Administration (“FDA”) for approval of its DeepView AI®-Burn system, a crucial milestone targeted for the first half of 2025.

Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call Transcript
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call Transcript
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call Transcript
MDAI
seekingalpha.comNovember 9, 2024

Spectral AI, Inc. (NASDAQ:MDAI ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Devin Sullivan - MD of Equity Group Michael DiMaio - Chairman Vincent Capone - CFO Conference Call Participants Ryan Zimmerman - BTIG Carl Byrnes - Northland Capital Markets RK Ramakanth - H.C. Wainwright John Vandermosten - Zacks Operator Good afternoon, and welcome to the Spectral AI Third Quarter 2024 Financial Results Conference Call.

Spectral AI to spin off subsidiary to focus on IP monetization, healthcare AI expansion
Spectral AI to spin off subsidiary to focus on IP monetization, healthcare AI expansion
Spectral AI to spin off subsidiary to focus on IP monetization, healthcare AI expansion
MDAI
proactiveinvestors.comNovember 6, 2024

Spectral AI Inc (NASDAQ:MDAI) announced plans to spin off its subsidiary, Spectral IP, Inc., through a deal with Sauvegarder Investment Management, Inc. (SIM). The transaction aims to position Spectral IP as an independent company with a broader focus on intellectual property (IP) monetization across various sectors, including healthcare, artificial intelligence, and semiconductors.

Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
MDAI
globenewswire.comNovember 6, 2024

Strategic Spinoff Aims to Unlock IP Value and Sharpen Focus on AI Medical Diagnostics Strategic Spinoff Aims to Unlock IP Value and Sharpen Focus on AI Medical Diagnostics

Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
MDAI
globenewswire.comOctober 23, 2024

DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2024 on Wednesday, November 6, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results.

AI in Wound Care Market Industry Research Report 2024-2035 Featuring Key Players - eKare, healthy.io, Kronikare, Intellicure, Perceptive Solutions, Spectral AI, Swift Medical, Wound Pros Among Others
AI in Wound Care Market Industry Research Report 2024-2035 Featuring Key Players - eKare, healthy.io, Kronikare, Intellicure, Perceptive Solutions, Spectral AI, Swift Medical, Wound Pros Among Others
AI in Wound Care Market Industry Research Report 2024-2035 Featuring Key Players - eKare, healthy.io, Kronikare, Intellicure, Perceptive Solutions, Spectral AI, Swift Medical, Wound Pros Among Others
MDAI
globenewswire.comOctober 23, 2024

Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "AI in Wound Care Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Wound, Type of Acute Wound, Type of Chronic Wound, Type of AI Technology, End User and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.

Spectral AI founder returns as board chairman
Spectral AI founder returns as board chairman
Spectral AI founder returns as board chairman
MDAI
proactiveinvestors.comOctober 15, 2024

Spectral AI Inc (NASDAQ:MDAI) announced that its founder Dr J Michael DiMaio has been appointed chairman of the board of directors. DiMaio, a seasoned cardiothoracic surgeon and former CEO of the company, is expected to lead Spectral AI through its next phase of growth, focusing on the commercialization and FDA approval of its DeepView System for wound care.

FAQ

  • What is the ticker symbol for Spectral AI?
  • Does Spectral AI pay dividends?
  • What sector is Spectral AI in?
  • What industry is Spectral AI in?
  • What country is Spectral AI based in?
  • When did Spectral AI go public?
  • Is Spectral AI in the S&P 500?
  • Is Spectral AI in the NASDAQ 100?
  • Is Spectral AI in the Dow Jones?
  • When was Spectral AI's last earnings report?
  • When does Spectral AI report earnings?
  • Should I buy Spectral AI stock now?

What is the ticker symbol for Spectral AI?

The ticker symbol for Spectral AI is NASDAQ:MDAI

Does Spectral AI pay dividends?

No, Spectral AI does not pay dividends

What sector is Spectral AI in?

Spectral AI is in the Healthcare sector

What industry is Spectral AI in?

Spectral AI is in the Medical Devices industry

What country is Spectral AI based in?

Spectral AI is headquartered in United States

When did Spectral AI go public?

Spectral AI's initial public offering (IPO) was on April 6, 2021

Is Spectral AI in the S&P 500?

No, Spectral AI is not included in the S&P 500 index

Is Spectral AI in the NASDAQ 100?

No, Spectral AI is not included in the NASDAQ 100 index

Is Spectral AI in the Dow Jones?

No, Spectral AI is not included in the Dow Jones index

When was Spectral AI's last earnings report?

Spectral AI's most recent earnings report was on Nov 6, 2024

When does Spectral AI report earnings?

The next expected earnings date for Spectral AI is Mar 27, 2025

Should I buy Spectral AI stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions